Target intelligence / Profile preview

Biological tissue ablation via direct current plasma discharge

Molecular classification
Other
01

Overview

Biological tissue ablation via direct current plasma discharge" refers to the use of a **plasma generated by a direct electrical discharge**—specifically using a continuous potential difference between electrodes—to physically destroy or modify biological tissues. This is not a molecular target such as an enzyme, receptor, or transporter; rather, it is a **medical technique** that employs the unique properties of plasmas for clinical purposes. Direct current plasma discharges can generate highly energetic electrons and ions at atmospheric pressure. When applied to biological tissues, these plasmas can induce cell death through both physical mechanisms (localized heating and disruption) and chemical mechanisms (generation of reactive species). Applications include tumor/cancer cell destruction, sterilization in medical settings, treatment of skin diseases and wounds, dental procedures, and other forms of minimally invasive surgery[3][4]. The method is part of the broader field known as "plasma medicine." Because this entry describes an **application/technique** rather than a discrete molecular entity or therapeutic target classically defined in pharmacology or molecular biology—and because it lacks specificity regarding any single molecule—it should be flagged as incorrect for structured drug-target databases. If you need information about specific molecules involved in the cellular response to plasma exposure—or about particular types/subtype s of gas/plasma discharges used in medicine—please clarify your request.

Other names
Direct current plasma ablationDC plasma tissue ablationPlasma-mediated tissue ablation (via direct current)Plasma medicine (context-specific)
02

Mechanism of action

Physical and chemical destruction of biological tissues through exposure to energetic plasma species generated by direct current electrical discharge[3][4].

03

Biological functions

Other (physical destruction of biological tissue)Cell death (induced by physical/chemical means)
04

Disease associations

Cancer (tumor ablation)Infection (sterilization)Other (surgical applications, dermatology)
05

Safety considerations

Non-specific thermal or chemical injury to surrounding healthy tissuesGeneration of reactive oxygen/nitrogen species with potential off-target effectsRisk of incomplete ablation or collateral damage depending on application parameters[3][5]

Beyond the preview

Go deeper on Biological tissue ablation via direct current plasma discharge.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological tissue ablation via direct current plasma discharge.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call